Related Experiment Video
Updated: May 27, 2026
07:27
The Murine Choline-Deficient, Ethionine-Supplemented (CDE) Diet Model of Chronic Liver Injury
Published on: October 21, 2017
[Carnitine: function, metabolism and value in hepatic failure during chronic alcohol intoxication]
Alina Kępka1, Sławomir Dariusz Szajda, Napoleon Waszkiewicz
1Zakład Biochemii i Medycyny Doświadczalnej, Instytut Pomnik-Centrum Zdrowia Dziecka w Warszawie. secesja71@poczta.onet.pl
Postepy Higieny I Medycyny Doswiadczalnej (Online)
|November 22, 2011
Summary
Chronic alcohol consumption damages the liver by disrupting fatty acid metabolism and carnitine pathways. L-carnitine supplementation shows promise for mitigating alcohol-induced liver injury and promoting recovery.
Area of Science:
- Biochemistry
- Hepatology
- Metabolic Disorders
Context:
- Alcoholism is a prevalent global health issue.
- Chronic alcohol intake leads to severe liver damage, including steatosis, inflammation, and cirrhosis.
- Ethanol disrupts key metabolic pathways, notably fatty acid oxidation and carnitine metabolism.
Purpose:
- To investigate the role of L-carnitine in counteracting alcohol-induced liver pathology.
- To elucidate the mechanisms by which L-carnitine may protect the liver from ethanol toxicity.
Summary:
- Chronic alcohol consumption impairs fatty acid oxidation by interfering with carnitine metabolism and the citric acid cycle.
- This metabolic disruption leads to ketosis and various forms of liver injury.
- L-carnitine, essential for fatty acid transport and beta-oxidation, stabilizes cell membranes and aids in removing excess acyl groups.
Impact:
- L-carnitine demonstrates potential as a safe and effective therapeutic agent for liver conditions associated with chronic alcohol abuse.
- Understanding carnitine's role offers new avenues for treating alcohol-related liver disease.
- This research highlights the importance of metabolic support in managing alcoholism's systemic effects.
Related Concept Videos
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
01:21Chronic Pancreatitis II: Pathophysiology
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
01:30Liver Physiology
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can also...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can also...
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...